[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627897":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":28,"responsibleParty":43,"collaborators":7,"id":45,"slug":7,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":7,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":63,"overallStatus":67,"whyStopped":7,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Wren Laboratories LLC","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","PROSTEST","BLOOD SAMPLE FOR PROSTEST MEASUREMENT",[14],{"name":15,"affiliation":16,"role":17},"Abdel Halim, PharmD, PhD","Wren Laboratories","STUDY_CHAIR",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"Mark Kidd, PhD","CONTACT","2038241128","mkidd@wrenlaboratories.com",{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},"Tracy Auster, BS","2032083464","tauster@wrenlaboratories.com",[29],{"facility":16,"status":7,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Branford","Connecticut","06405","United States",{"type":35,"coordinates":36},"Point",[37,38],-72.8151,41.27954,{"lat":38,"lon":37},[41,42],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},{"type":44,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100627897",false,"NCT07454603","A Prospective Clinical Trial Evaluating PROSTest, a Blood-Based Molecular Assay, for Risk Stratification and Biopsy Decision Support in Men With Suspected Prostate Cancer","PROSTest_STRAT","Inclusion Criteria:\n\n* elevated PSA and\u002For abnormal digital rectal examination\n\nExclusion Criteria:\n\n* Previous Prostate cancer diagnosis","MALE","45 Years","80 Years",{"count":55,"type":56},1500,"ESTIMATED","OBSERVATIONAL","This prospective observational study will enroll men referred for prostate biopsy due to elevated PSA and\u002For abnormal digital rectal examination, with or without pre-biopsy MRI. Peripheral blood will be collected prior to biopsy for PROSTest analysis. Biopsy histopathology will serve as the reference standard. PROSTest results will be analyzed blinded to pathology.",[60,61,62],"Prostate Cancer","Urology","Prostate Cancer (Diagnosis)",[64,65,66],"BIOPSY","MRI","PROSTATE CANCER","NOT_YET_RECRUITING","2026-03-02",{"date":70,"type":71},"2026-03-06","ACTUAL",{"date":73,"type":56},"2026-03-15",{"date":75,"type":56},"2027-06-01",{"name":5,"class":6},1]